NCT02463591View on ClinicalTrials.gov

Reversal of Dabigatran With Prothrombin Complex Concentrate

PHASE2UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

December 31, 2016

Conditions
Drug Action Reversal
Interventions
DRUG

Beriplex

Beriplex 50 IU/Kg i.v. , single dose.

Trial Locations (1)

9713 GZ

RECRUITING

University Medical Centre, Groningen

Sponsors
All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

CSL Behring

INDUSTRY

lead

University Medical Center Groningen

OTHER

NCT02463591 - Reversal of Dabigatran With Prothrombin Complex Concentrate | Biotech Hunter | Biotech Hunter